The trademark application rAAVen was filed by Raaven Therapeutics AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on September 25, 2024, and still open for oppositions.
It was designated 'Basic Application' for International Application 1821535 at the World Intellectual Property Organization (WIPO).
The application was filed in Swedish (English was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Research in the field of gene therapy
Biological research, clinical research and medical research
Medical research
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Scientific research for medical purposes in the area of cancerous diseases
Medical research laboratory services
Consultancy relating to research in the field of pharmacogenetics
Pharmaceutical research and development
Consultancy in the field of pharmaceutical research
Platform as a service [PaaS] featuring computer software platforms for use in screening and/or validation within gene therapy research..